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Abstract
Nitric oxide (NO) is assumed to contribute to the impairment of B-cell function in type 1 diabetes mellitus (IDDM). In the
present paper we show that in mouse B-cells with intact metabolism authentic NO (20 WM) led to a biphasic effect on the
KATP current, namely a transient increase and a consecutive almost complete inhibition. This resembles closely the effect that
we have observed previously with the NO donor S-nitrosocysteine (SNOC, 1 mM) suggesting that merely NO caused both
phases of this effect. We now demonstrate that the rise in the current amplitude was accompanied by a depolarization of the
mitochondrial membrane potential v8 and a concomitant reduction in the ATP/ADP ratio. Thus, it seems likely that the
increase in current amplitude is due to the interference of NO with cell metabolism. The subsequent inhibition of the KATP
current is assumed to be caused by a direct effect on the channel since KATP single channel current activity measured in
excised patches was strongly reduced by authentic NO and SNOC. Our data reveal new insights into the mechanisms
underlying the biphasic action of NO on KATP channels in pancreatic B-cells. ß 2000 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Nitric oxide (NO) participates in autoimmune re-
actions leading to severe disease states like type 1
diabetes mellitus [1]. It has been suggested that NO
produced by activated macrophages in vivo plays an
important role in the impairment of B-cell function
and ¢nally destruction [2]. According to its action in
the organisms NO is either synthesized in low con-
centrations by constitutive Ca2/calmodulin-depen-
dent isoforms of the NO synthase or in high concen-
trations by an inducible, not Ca2-regulated isoform
of the enzyme which is activated in response to cy-
tokines or endotoxins [3].
In a previous paper we have shown that the NO
donor S-nitrosocysteine (SNOC) evokes rapid
changes in the activity of ion channels and it was
concluded that this may lead to rapid changes in
B-cell function [4]. With low concentrations of
SNOC (10 WM and 100 WM) the whole-cell KATP
current measured in the perforated-patch mode in-
creased. However, with 1 mM of the NO donor the
e¡ect on the KATP current became biphasic. The ini-
tial increase was followed by a marked reduction of
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the current suggesting that at higher concentrations
SNOC displays two di¡erent e¡ects. We speculated
that the rise in the KATP current may be due to a
decrease in the intracellular ATP/ADP ratio while
the current inhibition could be caused by a direct
interaction of the NO donor with the channel or
tightly associated proteins. An increase in the KATP
channel activity by two other NO donors, sodium
nitroprusside (SNP) and S-nitroso-N-acetyl-DL-peni-
cillamine (SNAP) was observed in the cell-attached
mode by Tsuura et al. [5]. They also assumed that a
fall in the ATP/ADP ratio could be the reason for
this observation. It was one aim of this study to
prove (or reject) this hypothesis. Doubts have been
cast whether NO donors [6^9] evoke identical e¡ects
as authentic NO [10,11] on B-cell function. There-
fore, the e¡ects of authentic NO gas on the KATP
current and the mitochondrial membrane potential
v8 as an indicator for ATP production were inves-
tigated and compared to the e¡ects of the NO donor
SNOC.
Parts of the study have been published earlier in
abstract form [12].
2. Material and methods
2.1. Cell and islet preparation
The experiments were performed on islets or single
cells of fed female NMRI mice (25^30 g), killed by
cervical dislocation. Islets were isolated by collage-
nase digestion of the pancreas. For patch-clamp ex-
periments and measurements of v8 islet cells were
dispersed in Ca2-free medium and cultured up to
3 days in RPMI 1640 medium supplemented with
10% fetal calf serum, 100 U/ml penicillin and
100 Wg/ml streptomycin [13]. ATP/ADP ratio was
determined with freshly prepared islets.
2.2. Solutions and chemicals
To record currents through single KATP channels
at 32‡C, seals were obtained using a pipette solution
composed of (in mM): 130 KCl, 1.2 MgCl2, 2 CaCl2,
10 EGTA, 20 HEPES, pH 7.4 adjusted with KOH.
The bath solution used for perifusion of the cells
(solution 1) was composed of (in mM): 140 NaCl,
5 KCl, 1.2 MgCl2, 2.5 CaCl2, 0.5 glucose, 10 HEPES,
pH 7.4 adjusted with NaOH. Before patch excision,
the bath solution was replaced by a Mg2-free solu-
tion (solution 2) with the following composition (in
mM): 130 KCl, 4.6 CaCl2, 10 EDTA, 20 HEPES,
pH 7.20 adjusted with KOH. The lack of Mg2 and
ATP in this solution prevents phosphorylation and
reduced KATP channel rundown probably by this
mechanism [14,15]. Whole-cell KATP current record-
ings were performed at 32‡C with nystatin in the
pipette solution (150^250 WM). The pipette solution
also contained (in mM): 10 KCl, 10 NaCl, 70 K2SO4,
4 MgCl2, 2 CaCl2, 10 EGTA, 20 HEPES, pH 7.15
adjusted with KOH. The bath solution was the same
as for the measurements of single KATP channels
used before patch excision (solution 1). This bath
solution was also used for the determination of v8
at 37‡C. ATP/ADP ratio was determined in a steady-
state incubation at 37‡C with a bath solution (solu-
tion 3) of the following composition (in mM):
122 NaCl, 4.7 KCl, 1.1 MgCl2, 2.5 CaCl2, 10 HEPES,
15 glucose, supplemented with 0.5% BSA. Conven-
tional whole-cell recordings were performed as de-
scribed earlier [16].
SNOC was freshly synthesized immediately before
each use as follows: an equimolar solution of
100 mM sodium nitrite and cysteine in H2O was
prepared, acidi¢ed with HCl for S-nitrosylation
(pH6 2) and neutralized with NaOH [17]. For the
preparation of the NO solution an air-tight bottle
containing 10 ml H2O was bubbled with nitrogen
for 30 min at 4‡C. Afterwards, this solution was
bubbled with NO gas for 15 min at 4‡C, yielding a
saturated solution of approx. 1.9 mM NO at 25‡C
[18]. Rhodamine 123 was obtained from Molecular
Probes (Eugene, OR, USA), NO gas and nitrogen
from Messer Griesheim (Reutlingen, Germany).
ATP and ADP were from Boehringer (Mannheim,
Germany), the BioOrbit 1243-102 ATP-monitoring
kit from Merlin Diagnostika (Bornheim-Fersel, Ger-
many). All other chemicals were purchased from
Merck (Darmstadt, Germany) in the purest form
available.
2.3. Recording methods
Whole-cell KATP currents were measured at 32‡C
in the perforated-patch con¢guration at a holding
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potential of 370 mV and during 300 ms pulses to
380 mV and 360 mV at 15 s intervals. Under these
experimental conditions the current is almost entirely
KATP current blockable by tolbutamide [19]. Single
KATP channel currents were recorded in inside-out
patches at 32‡C at a membrane potential of 350
mV. Open probabilities (Po) were calculated for a
recording time of 30 s. Patch-clamp recordings
were performed and evaluated with an EPC-9
patch-clamp ampli¢er and software ‘Pulse’ (HEKA,
Lambrecht, Germany). For o¡-line analysis, data
were stored on video tape, played back by means
of a MacLab4S interface with software ‘Chart’
(WissTech, Spechbach, Germany) and evaluated
with ‘Igor’ (WaveMetrics, Lake Oswego, OR, USA).
ATP/ADP ratio was determined by measuring
ATP and ADP in the same batch of eight islets. At
the end of the incubation period extracellular £uid
was sucked o¡ and islets were disintegrated with
NaOH/cysteine solution (40 mM/0.5 mM) and stored
at 320‡C. For luminescence measurements aliquots
of each sample were dissolved with a bu¡er contain-
ing (in mM): 20 creatine phosphate, 100 glycine,
1 MgSO4 at pH 9.0 with or without creatine kinase
(20 pg/ml). Aliquots were either neutralized with HCl
to pH 7.65 immediately or after an incubation with
creatine kinase for 10 min at room temperature to
convert all ADP to ATP. ATP concentration was
measured in a luciferin/luciferase assay using the
ATP-monitoring kit with the luminescence biometer
1253 (Bio-orbit, Merlin).
The mitochondrial membrane potential (v8) was
measured by determining the rhodamine 123 £uores-
cence on an Axiovert 100 microscope (Zeiss, Stutt-
gart, Germany) with an equipment and software de-
livered by TILL photonics (Planegg, Germany).
Excitation light wavelength (480 nm) was adjusted
by means of a di¡ractive grating and then directed
through the objective (PlanNeo£uar 40U, Zeiss) by
means of a glass ¢bre light guide and a dichroic
mirror. The emitted light was ¢ltered (LP 515 nm)
and measured by a CCD camera. Single cells or
small clusters of cells were loaded with rhodamine
123 (10 Wg/ml) for 10 min at 37‡C. An increase of
Rh 123 £uorescence corresponds to a decrease of
mitochondrial membrane potential [20].
Where applicable, experimental data are expressed
as arithmetic means þ S.E.M. Statistical signi¢cance
was accepted at P9 0.05.
3. Results
3.1. E¡ects of NO on KATP
+ whole-cell currents of
mouse pancreatic B-cells
We have tested authentic NO gas on the KATP
whole-cell current measured in the perforated-patch
mode. At a concentration of 20 WM a biphasic e¡ect
was observed in all cells tested. The initial increase in
the KATP current was followed by a marked, irrevers-
ible suppression of the current (Fig. 1). On average,
Fig. 1. E¡ect of NO (20 WM) on KATP whole-cell current of mouse pancreatic B-cells. The K

ATP whole-cell currents were measured
with the perforated-patch technique. Bath solution under control conditions was solution 1. NO was added to the bath solution dur-
ing the time indicated by the solid horizontal bar. The current is shown at the holding potential of 370 mV (solid line) and during
300 ms steps to 380 and 360 mV (lower dashed trace and upper dashed trace, respectively). This record is representative of six ex-
periments with similar results. The inset shows for comparison the e¡ect of the NO donor S-nitrosocysteine (SNOC, 1 mM) on the
perforated-patch KATP whole-cell current as published earlier [4].
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the current under control conditions elicited by a
10 mV depolarizing step was 25 þ 6 pA (n = 6). After
addition of 20 WM NO the KATP current ¢rst in-
creased to 121 þ 24 pA and afterwards decreased to
18 þ 6 pA (n = 6). For comparison the inset shows the
e¡ect of the NO donor SNOC at a concentration of
1 mM on the KATP current that has been published
earlier [4]. With 2 WM NO the current increased in
eight out of 11 experiments from 18 þ 9 pA to 66 þ
27 pA (not shown). In four of these experiments the
rise induced by 2 WM NO was transient and the
current decreased to 3 þ 1 pA. In three out of the
11 experiments no alteration of the current by 2 WM
NO was observed.
3.2. E¡ects of SNOC and NO on the ATP/ADP ratio
and the mitochondrial membrane potential in
mouse pancreatic B-cells
It seemed likely that the increase in the KATP
whole-cell current observed in the perforated-patch
con¢guration is due to a metabolic factor since no
increase in the KATP current amplitude was observed
even with 10 mM SNOC in the standard whole-cell
con¢guration in which the cell interior is dialysed by
the pipette solution (n = 13, not shown). To elucidate
whether this metabolic factor is ATP we have mea-
sured the ATP/ADP ratio (Fig. 2A). The left column
shows the ATP/ADP ratio in the presence of 15 mM
glucose before the addition of SNOC which mounted
up to 3.03 þ 0.21 (n = 5). Addition of 0.1 mM and
1 mM SNOC (right columns) for 10 min signi¢cantly
reduced the ATP/ADP ratio to 2.06 þ 0.21 (n = 5,
P6 0.05) and 1.45 þ 0.06 (n = 5, P6 0.05), respec-
tively. If only control solution is added the ATP/
ADP ratio remained unchanged during this period
of 10 min (2.92 þ 0.11, n = 5, right column). The
ATP/ADP ratio is determined in a steady-state incu-
bation and does not allow to estimate the time
course of changes. Thus, for an on-line registration
we have monitored changes in rhodamine £uores-
cence re£ecting alterations in the mitochondrial
membrane potential v8 which are assumed to be
indicative of changes in ATP synthesis [21]. SNOC
induced a rapid, dose-dependent depolarization of
v8 (Fig. 2B). On average, the change in arbitrary
units (a.u.) was 1043 þ 115 and 1688 þ 74 after addi-
tion of 0.1 mM and 1 mM SNOC, respectively
(n = 4). The addition of 2 WM (n = 8) or 20 WM
(n = 10) NO in the presence of 15 mM glucose also
strongly depolarized v8 (Fig. 2C). On average, the
change induced by 2 WM and 20 WM NO gas was
368 þ 53 a.u. and 673 þ 98 a.u., respectively. In con-
trast to SNOC which continuously releases NO, the
e¡ects with NO gas were at least partly transient
Fig. 2. E¡ect of NO and SNOC on the ATP/ADP ratio and
the mitochondrial membrane potential (v8) of mouse pancreat-
ic B-cells. (A) Mean changes in the ATP/ADP ratio were moni-
tored 10 min after addition of 0.1 mM and 1 mM SNOC to
the incubation medium (solution 3). The left column represents
the ATP/ADP ratio under control conditions with bath solution
3, containing 15 mM glucose. Values are means þ S.E.M. of ¢ve
experiments. (B) The mitochondrial membrane potential v8 has
been monitored continuously. 0.1 mM and 1 mM SNOC have
been added in the presence of 15 mM glucose at the time indi-
cated by the horizontal bars. This recording is representative of
four experiments with similar results. (C) Continuous registra-
tion of v8. NO (2 WM and 20 WM) was added during the time
indicated by the horizontal bars at 15 mM glucose. The record-
ing represents 8^10 experiments for the individual manoeuvres.
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probably due to the rapid decomposition of the mol-
ecule.
3.3. E¡ects of NO and SNOC on single KATP
+
channels of mouse pancreatic B-cells
We have suggested that the inhibitory e¡ect of NO
and SNOC on the KATP whole-cell current is caused
by a direct interaction with the KATP current by af-
fecting the channel itself or proteins closely related to
it. To prove this assumption we have tested the e¡ect
of the compounds on single channel current activity
in inside-out patches. As shown in Fig. 3A 20 WM
NO almost completely and irreversibly inhibited the
single channel current activity. Under control condi-
tions up to ¢ve channels were simultaneously open.
On average, Po was reduced from 0.67 þ 0.14 under
control conditions to 0.02 þ 0.02 after addition of
NO (n = 5). Fig. 3B demonstrates that the KATP sin-
gle channel activity is also markedly and irreversibly
reduced after addition of 1 mM of the NO donor
SNOC to the bath solution. Under control condi-
tions up to ¢ve channels opened simultaneously.
On average, 1 mM SNOC reduced Po from
0.20 þ 0.03 (n = 7) under control conditions to
0.01 þ 0.01 (n = 7). In time-matched controls no re-
duction of the single channel current activity was
observed (n = 9, not shown).
4. Discussion
Overwhelming evidence has accumulated that NO
contributes to the impairment of B-cell function and
to the eventual destruction of B-cells during the de-
velopment of IDDM. NO might be produced by ac-
tivated macrophages [22], activated islet endothelial
cells [23] or by the B-cells themselves in response to
cytokines [24]. NO has been shown to interfere with
enzymes of the glycolysis [25] and the citric acid cycle
[26] and to mediate DNA damage accompanied by
NAD depletion [27,28]. Moreover, the use of NO
donors led to the suggestion that NO also induces
rapid changes of the membrane potential and the ion
channel activity in B-cells [4,5]. Tsuura et al. [5] have
shown that the NO donors SNP and SNAP open
KATP channels of mouse pancreatic B-cells with in-
tact cell metabolism. The use of several insulin sec-
retagogues and intermediates of glycolysis led them
to suggest that inhibition of phosphofructokinase is
responsible for the impairment of glucose metabo-
lism by NO. We have demonstrated that the NO
donor SNOC hyperpolarizes the B-cell membrane
measured with intracellular microelectrodes in intact
islets and increases the KATP whole-cell current reg-
istered in the perforated-patch mode with intact cell
metabolism at concentrations between 0.01 and 1 mM
[4]. However, at the high concentration of the NO
donor the augmentation of the current was followed
by a strong inhibition pointing to two di¡erent
modes of action of the compound. The e¡ect of au-
thentic NO gas at a concentration of 20 WM on
whole-cell KATP current measured in the perfo-
rated-patch mode was also biphasic and almost iden-
Fig. 3. E¡ects of NO (20 WM) and SNOC (1 mM) on single
KATP channel currents of mouse pancreatic B-cells. The regis-
trations have been performed in the inside-out patch con¢gura-
tion at a membrane potential of 350 mV. Bath solution under
control conditions was solution 2. c represents the closed state.
(A) NO was added to the bath solution during the time indi-
cated by the horizontal bar. This record is representative of ¢ve
experiments with similar results. * indicates an interruption of
2 min. (B) SNOC was added to the bath solution during the
time indicated by the horizontal bar. The recording is represen-
tative of seven experiments with similar results.
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tical to the e¡ect of 1 mM SNOC suggesting that the
stimulatory and the inhibitory e¡ect of SNOC on the
KATP current is caused by NO. At a concentration of
2 WM NO had either no e¡ect on the KATP current or
steadily increased it (similar to low concentrations of
SNOC [4]) or evoked the biphasic e¡ect also ob-
served with the higher concentration. The di¡erence
in the concentration dependence of the two e¡ects by
roughly two orders of magnitude [4] may also ex-
plain why the activating e¡ect of NO occurs much
earlier in the experiments than the inhibition of the
KATP current. In this context it is interesting that
Brorson and coworkers [29] reported that a SNOC
concentration of 1 mM resulted in a mean NO con-
centration of approx. 10 WM during a period of
20 min at 22‡C.
The present paper discloses correlations between
the action of NO and SNOC on the KATP current
and B-cell metabolism. The increase in the current
amplitude can be attributed to a diminution of the
ATP/ADP ratio by SNOC and NO. An increase in
the glucose concentration is accompanied by a hyper-
polarization of v8 re£ecting a rise in ATP synthesis
[21]. This is con¢rmed by our own observations (data
not shown). SNOC depolarized v8 in a concentra-
tion-dependent manner. Thus, we assume that v8
indeed changes in parallel with the ATP/ADP ratio
and that alterations in v8 can be taken as a measure
for changes in ATP synthesis in our cell system. NO
also depolarized v8 suggesting an inhibition of ATP
production. Consistently, it has been reported re-
cently that NO released from NO donors produced
a rapid, reversible depolarization of the mitochon-
drial membrane potential and depletion of cellular
ATP in cultured hippocampal neurones [29]. Addi-
tionally, it has been shown that NO donors activate
the poly(ADP-ribose) polymerase (PARP) in islet
cells [28], an e¡ect which by the consumption of re-
duction equivalents will of course contribute to the
ATP diminution of the cells in response to NO.
Nevertheless, to our knowledge direct e¡ects of NO
or NO donors on the ATP content in pancreatic islet
cells have not been shown before. However, the
ATP/ADP ratio is diminished after exposure of islets
to the cytokine interleukin-1L [30] which is known to
induce the formation of NO in islets [31,25,32] and
islet B-cells [26].
Since NO and SNOC inhibited the single channel
current activity in excised patches it seems justi¢ed to
speculate that the inhibitory action can be explained
by a direct interaction of NO with the channel or
closely related proteins. NO has been shown to react
with cysteine-free SH groups of serum and plasma
membrane associated proteins [33^36]. Thus, it is
conceivable that NO and SNOC act on SH groups
essential for the regulation of KATP channels in B-
cells. It has been shown previously that SH group
reagents directly inhibit B-cell KATP currents [37^
39] and that the inhibition is more pronounced
when the reagent is membrane permeant so that it
can act at the cytosolic side [39]. Furthermore, it was
found for B-cell KATP channels and mutations ex-
pressed in oocytes that the relevant cysteine residue
for channel inhibition by SH group reagents is at
position 42 of the cytosolic NH2-terminal part of
Kir6.2 [40].
In conclusion, the data presented in this study re-
veal that NO as well as the NO donor SNOC evoke
a complex pattern of interaction with pancreatic
KATP channels: the K

ATP current is stimulated by
in£uencing B-cell metabolism via a reduction in the
ATP/ADP ratio and on the other hand inhibited by
direct interference with the channel or a regulatory
protein in its close vicinity.
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